Bausch Health
BHC
346 hedge funds and large institutions have $7.04B invested in Bausch Health in 2021 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 101 increasing their positions, 128 reducing their positions, and 43 closing their positions.
56% more call options, than puts
Call options by funds: $327M | Put options by funds: $210M
0.44% more ownership
Funds ownership: 69.82% → 70.27% (+0.44%)
4% less capital invested
Capital invested by funds: $7.34B → $7.04B (-$300M)
3% less funds holding
Funds holding: 357 → 346 (-11)
14% less funds holding in top 10
Funds holding in top 10: 22 → 19 (-3)
16% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 43
21% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 128
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$283M |
| 2 |
IG
ING Group
Amsterdam,
Netherlands
|
+$56.7M |
| 3 |
CLG
Cooperman Leon G
|
+$51.4M |
| 4 |
GAM
Goldentree Asset Management
New York
|
+$33.3M |
| 5 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$183M |
| 2 |
Morgan Stanley
New York
|
-$32.2M |
| 3 |
Two Sigma Investments
New York
|
-$31.3M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28.4M |
| 5 |
Millennium Management
New York
|
-$27.7M |
BHC Hedge Fund Activity: Q3 2021 in Review
346 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2021, worth a combined $7.04B — down 4.1% from $7.34B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of BHC and 36 opened new positions — a net loss of 7 holders — while 128 trimmed existing stakes and 101 added.
The largest buyer was Nomura Holdings, adding an estimated $283M. The largest seller was T. Rowe Price Associates, cutting an estimated $183M.
- 346 institutional investors held Bausch Health (BHC) as of Q3 2021, down from 357 in Q2 2021.
- Funds reported $7.04B of Bausch Health stock for Q3 2021, down 4.1% quarter-over-quarter.
- 36 funds opened new Bausch Health positions in Q3 2021 and 43 closed out, a net change of -7 holders.
- The largest Bausch Health buyer in Q3 2021 was Nomura Holdings, an estimated $283M added.
- The largest Bausch Health seller in Q3 2021 was T. Rowe Price Associates, an estimated $183M sold.
Based on aggregated 13F filings for Q3 2021.